Home › Non-Small Cell Lung Cancer › Texas › El Paso
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa El Paso, TX
6 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng El Paso (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Texas Oncology-West Texas, El Paso
- Texas Oncology-West Texas, El Paso
- Texas Oncology-West Texas, El Paso
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Texas Oncology - West Texas, El Paso
- Texas Oncology - West Texas, El Paso
- Texas Oncology - West Texas, El Paso
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
- Renovatio Clinical - El Paso, El Paso
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Nagre-recruitPhase 2/3
- Local Institution - 007-554E, El Paso
- Local Institution - 007-554C, El Paso
- Local Institution - 007-554F, El Paso
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- William Beaumont Army Medical Center, Fort Bliss · 6 mi ang layo
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Renovatio Clinical - El Paso, El Paso
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa El Paso
- Obesity10 pag-aaral
- Overweight8 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Kanser sa Suso6 pag-aaral
- COPD5 pag-aaral
- Metastatic Cancer5 pag-aaral
- Atherosclerosis4 pag-aaral
- Sakit ni Alzheimer4 pag-aaral
- Burkitt Lymphoma4 pag-aaral
- Kanser (lahat ng uri)4 pag-aaral
- Asthma4 pag-aaral
- Idiopathic Pulmonary Fibrosis4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.